August 20, 2014 / 10:59 AM / 3 years ago

BUZZ-Emergent BioSolutions Inc: To develop cancer drug with MorphoSys

** Drugmaker’s shares up 21 pct at $28.42 premarket

** Signs agreement with Germany’s MorphoSys AG to develop and market its antibody targeting prostate cancer cells

** Emergent to get upfront payment of $20 million and potential milestone payments of up to $163 million

** Plans to start early-stage trial in prostate cancer patients within six months

** Emergent to get marketing rights in North America and MorphoSys in the rest of the world

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below